Gene based therapies for kidney regeneration.

Area of Science:

• Molecular Biology
• Nephrology
• Biotechnology

Background:

• Kidney diseases encompass a wide range of conditions, many with limited treatment options.
• Gene-based therapies represent a novel approach to address the underlying molecular causes of kidney disorders.
• Current treatments often manage symptoms rather than offering cures for genetic or chronic kidney diseases.

Purpose of the Study:

• To review the expanding molecular toolbox for gene-based therapies in kidney diseases.
• To explore the application of gene therapies for both genetic and chronic kidney disorders.
• To discuss the potential, limitations, and emerging technologies in renal gene therapy.

Main Methods:

• Overview of gene-based therapy strategies: gene addition, gene regulation, and gene editing.
• Discussion of recombinant DNA delivery for therapeutic gene expression.
• Examination of emerging technologies like CRISPR/Cas9 for gene repair.

Main Results:

• Gene therapies can restore gene function, regulate gene expression, or edit DNA sequences to treat kidney diseases.
• Delivery methods and therapeutic gene action are crucial for efficacy and safety.
• Various gene-based approaches show potential for kidney regeneration and disease management.

Conclusions:

• Gene-based therapies offer promising avenues for treating a diverse spectrum of kidney diseases.
• Emerging technologies like CRISPR/Cas9 are expanding the possibilities for gene repair and treatment.
• Further research into efficient delivery and safety is essential to realize the full potential of renal gene therapy.